ORIGINAL ARTICLE
Lung cancer risk score for ever and never smokers in China
Zhimin Ma, Jun Lv, Meng Zhu, Canqing Yu, Hongxia Ma, Guangfu Jin, Yu Guo, Zheng Bian, Ling Yang, Yiping Chen, Zhengming Chen, Zhibin Hu, Liming Li, Hongbing Shen
Cancer Communications 2023 43: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 7/6/2023 doi:10.1002/cac2.12463
ORIGINAL ARTICLE
HMMR alleviates endoplasmic reticulum stress by promoting autophagolysosomal activity during endoplasmic reticulum stress-driven hepatocellular carcinoma progression
Lin He, Hao Li, Can Li, Ze-Kun Liu, Meng Lu, Ren-Yu Zhang, Dong Wu, Ding Wei, Jie Shao, Man Liu, Hao-Lin Wei, Cong Zhang, Zhe Wang, Ling-Min Kong, Zhi-Nan Chen, Huijie Bian
Cancer Communications 2023 43: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 7/5/2023 doi:10.1002/cac2.12464
LETTER TO THE EDITOR
Clinical utility of circulating tumor DNA sequencing with a large panel in patients with advanced soft-tissue sarcomas
Julie Blanchi, Sofiane Taleb, Arnaud Bayle, Benjamin Verret, Maud Toulmonde, Mariella Spalato-ceruso, Paul Dubos, Yech'an Laizet, Melissa Alame, Emmanuel Khalifa, Antoine Italiano
Cancer Communications 2023 43: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 7/5/2023 doi:10.1002/cac2.12461
ORIGINAL ARTICLE
Positron emission tomography-adapted therapy in low-risk diffuse large B-cell lymphoma: results of a randomized, phase III, non-inferiority trial
Qing Shi, Yang He, Hong-Mei Yi, Rong-Ji Mu, Xu-Feng Jiang, Di Fu, Lei Dong, Wei Qin, Peng-Peng Xu, Shu Cheng, Qi Song, Sai-Juan Chen, Li Wang, Wei-Li Zhao
Cancer Communications 2023 43: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 7/4/2023 doi:10.1002/cac2.12462
ORIGINAL ARTICLE
USP51/PD-L1/ITGB1-deployed juxtacrine interaction plays a cell-intrinsic role in promoting chemoresistant phenotypes in non-small cell lung cancer
Jianjun Li, Xuechun Xiao, Yang Ou, Lixia Cao, Min Guo, Chunchun Qi, Zhaoyang Wang, Yuxin Liu, Qiuying Shuai, Hang Wang, Peiqing Sun, Yi Shi, Guang Yang, Shuang Yang
Cancer Communications 2023 43: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 6/29/2023 doi:10.1002/cac2.12460
ORIGINAL ARTICLE
Safety and immunogenicity of a third dose of mRNA-1273 vaccine among cancer patients
Anna Giuliano, Barbara Kuter, Shari Pilon-Thomas, Junmin Whiting, Qianxing Mo, Brett Leav, Bradley Sirak, Christopher Cubitt, Christopher Dukes, Kimberly Isaacs-Soriano, Kayoko Kennedy, Somedeb Ball, Ning Dong, Akriti Jain, Patrick Hwu, Jeffrey Lancet
Cancer Communications 2023 43: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 6/28/2023 doi:10.1002/cac2.12453
ORIGINAL ARTICLE
MFN2 suppresses clear cell renal cell carcinoma progression by modulating mitochondria-dependent dephosphorylation of EGFR
Li Luo, Denghui Wei, Yihui Pan, Qiu-Xia Wang, Jian-Xiong Feng, Bing Yu, Tiebang Kang, Junhang Luo, Jiefeng Yang, Song Gao
Cancer Communications 2023 43: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 6/28/2023 doi:10.1002/cac2.12428
ORIGINAL ARTICLE
Differential risk of 23 site-specific incident cancers and cancer-related mortality among patients with metabolic dysfunction-associated fatty liver disease: a population-based cohort study with 9.7 million Korean subjects
Goh Eun Chung, Su Jong Yu, Jeong-Ju Yoo, Yuri Cho, Kyu-na Lee, Dong Wook Shin, Yoon Jun Kim, Jung-Hwan Yoon, Kyungdo Han, Eun Ju Cho
Cancer Communications 2023 43: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 6/19/2023 doi:10.1002/cac2.12454
LETTER TO THE EDITOR
Loss of CDKN1B induces an age-related clonal hematopoietic disorder via Notch2 activity dysregulation
Ilenia Segatto, Gian Luca Rampioni Vinciguerra, Ilenia Pellarin, Alessandra Dall'Acqua, Stefania Berton, Francesca Citron, Sara D'Andrea, Giorgia Mungo, Davide Viotto, Lorena Musco, Arianna Di Napoli, Maria Antonietta Aloe Spiriti, Vincenzo Canzonieri, Valter Gattei, Andrea Vecchione, Barbara Belletti, Gustavo Baldassarre
Cancer Communications 2023 43: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 6/19/2023 doi:10.1002/cac2.12444
LETTER TO THE EDITOR
A phase II study on Mefatinib as first-line treatment of patients with advanced non-small-cell lung cancer harboring uncommon EGFR mutations
Pingli Wang, Liming Cao, Panwen Tian, Shengxiang Ren, Liyun Miao, Chengzhi Zhou, Yun Fan, Yuping Li, Dongqing Lv, Xin Zhao, Mei Yang, Chaonan Zhu, Bing Yu, June Xu, Yong Song, Kai Wang
Cancer Communications 2023 43: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 6/15/2023 doi:10.1002/cac2.12456
